Search Results 41-50 of 15662 for Atrophy
About this study. To evaluate whether SSRI use is associated with increased survival time and slower disease progression among patients with MSA.
The progressive loss of skeletal muscle mass that accompanies aging (sarcopenia) and disease (cachexia) can impair muscle performance, physical function and ...
The purpose of this study is to determine the effectiveness of Rifampicin in slowing or reversing the progression of multiple system atrophy. Participation ...
Multiple system atrophy causes a movement disorder, such as ataxia or parkinsonism. It also can cause low blood pressure, bladder symptoms and acting out dreams ...
The purpose of this study is to compare the effectiveness of BHV-3241 versus placebo in subjects with Multiple System Atrophy. Participation eligibility.
The syndrome used to be called atrophic vaginitis or vaginal atrophy. With this condition, vaginal tissues become thinner and irritated more easily. This is ...
Long-Term Follow-Up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA) · Overview · Participation eligibility · Participating Mayo Clinic ...
The purpose of this study is to evaluate the effectiveness of Lu AF82422 on disease progression in patients with Multiple System Atrophy (MSA). Participation ...
This disease of the heart muscle makes it harder for the heart to pump blood to the rest of the body. Learn the different types and how they're treated.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.